<?xml version="1.0" encoding="UTF-8"?>
<ref id="B114-pharmaceuticals-13-00096">
 <label>114.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tay</surname>
    <given-names>M.Y.</given-names>
   </name>
   <name>
    <surname>Fraser</surname>
    <given-names>J.E.</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>W.K.</given-names>
   </name>
   <name>
    <surname>Moreland</surname>
    <given-names>N.J.</given-names>
   </name>
   <name>
    <surname>Rathore</surname>
    <given-names>A.P.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Vasudevan</surname>
    <given-names>S.G.</given-names>
   </name>
   <name>
    <surname>Jans</surname>
    <given-names>D.A.</given-names>
   </name>
  </person-group>
  <article-title>Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin</article-title>
  <source>Antivir. Res.</source>
  <year>2013</year>
  <volume>99</volume>
  <fpage>301</fpage>
  <lpage>306</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2013.06.002</pub-id>
  <?supplied-pmid 23769930?>
  <pub-id pub-id-type="pmid">23769930</pub-id>
 </element-citation>
</ref>
